Clinical impact of gene mutations and lesions detected by SNP-array karyotyping in acute myeloid leukemia patients in the context of gemtuzumab ozogamicin treatment: Results of the ALFA-0701 trial

We recently showed that the addition of fractionated doses of gemtuzumab ozogamicin (GO) to standard chemotherapy improves clinical outcome of acute myeloid leukemia (AML) patients. In the present study, we performed mutational analysis of 11 genes (FLT3, NPM1, CEBPA, MLL, WT1, IDH1/2, RUNX1, ASXL1,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Renneville, Aline, Abdelali, Raouf Ben, Chevret, Sylvie, Nibourel, Olivier, Cheok, Meyling, Pautas, Cécile, Duléry, Rémy, Boyer, Thomas, Cayuela, Jean-Michel, Hayette, Sandrine, Raffoux, Emmanuel, Farhat, Hassan, Boissel, Nicolas, Terre, Christine, Dombret, Hervé, Castaigne, Sylvie, Preudhomme, Claude
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2014
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4011594/
https://ncbi.nlm.nih.gov/pubmed/24659740
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados